Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence X Yu

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
The AAPS Journal|July 19, 2014
Completeness assessment of type II active pharmaceutical ingredient drug master files under generic drug user fee amendment: review metrics and common incomplete itemsHuyi Zhang, Haitao Li, Wei Song, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 16, 2007
Validation and application of a stability-indicating HPLC method for the in vitro determination of gastric and intestinal stability of venlafaxineEbenezer B Asafu-Adjaye, Patrick J Faustino, Mobin A Tawakkul, et al.
The AAPS Journal|November 6, 2010
Scientific considerations for generic synthetic salmon calcitonin nasal spray productsSau L Lee, Lawrence X Yu, Bing Cai, et al.
Molecular Pharmaceutics|August 2, 2005
Permeability dominates in vivo intestinal absorption of P-gp substrate with high solubility and high permeabilityXianhua Cao, Lawrence X Yu, Catalin Barbaciru, et al.
Pharmaceutical Research|February 1, 2008
The use of BDDCS in classifying the permeability of marketed drugsLeslie Z Benet, Gordon L Amidon, Dirk M Barends, et al.
The Annals of Pharmacotherapy|September 25, 2009
Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug AdministrationBarbara M Davit, Patrick E Nwakama, Gary J Buehler, et al.
The AAPS Journal|June 22, 2012
Statistics on BCS classification of generic drug products approved between 2000 and 2011 in the USAAnil K Nair, Om Anand, Nam Chun, et al.
International Journal of Pharmaceutics: X|March 28, 2024
A network of regulatory innovations to improve FDA quality assessments of human drug applicationsRussie Tran, Grace Fraser, Adam C Fisher, et al.
Pharmaceutical Research|September 25, 2007
Bioequivalence approaches for highly variable drugs and drug productsSam H Haidar, Barbara Davit, Mei-Ling Chen, et al.
Pharmaceutical Research|July 15, 2006
Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat modelXianhua Cao, Seth T Gibbs, Lanyan Fang, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
The AAPS Journal|July 19, 2014
Completeness assessment of type II active pharmaceutical ingredient drug master files under generic drug user fee amendment: review metrics and common incomplete itemsHuyi Zhang, Haitao Li, Wei Song, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 16, 2007
Validation and application of a stability-indicating HPLC method for the in vitro determination of gastric and intestinal stability of venlafaxineEbenezer B Asafu-Adjaye, Patrick J Faustino, Mobin A Tawakkul, et al.
The AAPS Journal|November 6, 2010
Scientific considerations for generic synthetic salmon calcitonin nasal spray productsSau L Lee, Lawrence X Yu, Bing Cai, et al.
Molecular Pharmaceutics|August 2, 2005
Permeability dominates in vivo intestinal absorption of P-gp substrate with high solubility and high permeabilityXianhua Cao, Lawrence X Yu, Catalin Barbaciru, et al.
Pharmaceutical Research|February 1, 2008
The use of BDDCS in classifying the permeability of marketed drugsLeslie Z Benet, Gordon L Amidon, Dirk M Barends, et al.
The Annals of Pharmacotherapy|September 25, 2009
Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug AdministrationBarbara M Davit, Patrick E Nwakama, Gary J Buehler, et al.
The AAPS Journal|June 22, 2012
Statistics on BCS classification of generic drug products approved between 2000 and 2011 in the USAAnil K Nair, Om Anand, Nam Chun, et al.
International Journal of Pharmaceutics: X|March 28, 2024
A network of regulatory innovations to improve FDA quality assessments of human drug applicationsRussie Tran, Grace Fraser, Adam C Fisher, et al.
Pharmaceutical Research|September 25, 2007
Bioequivalence approaches for highly variable drugs and drug productsSam H Haidar, Barbara Davit, Mei-Ling Chen, et al.
Pharmaceutical Research|July 15, 2006
Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat modelXianhua Cao, Seth T Gibbs, Lanyan Fang, et al.
Pageof 8